Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul L Swiecicki

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Current Clinical Pharmacology|May 19, 2016
Axitinib in the Treatment of Head and Neck MalignanciesPaul L Swiecicki, Matthew Spector, Francis P Worden
World Journal of Clinical Oncology|February 11, 2016
Advanced oropharyngeal squamous cell carcinoma: Pathogenesis, treatment, and novel therapeutic approachesPaul L Swiecicki, Kelly M Malloy, Francis P Worden
Mayo Clinic Proceedings|August 6, 2013
35-year-old man with Fever and abdominal painLivia T Hegerova, Paul L Swiecicki, Shaji K Kumar
Blood|June 13, 2013
Cold agglutinin diseasePaul L Swiecicki, Livia T Hegerova, Morie A Gertz
Cancer Journal (Sudbury, Mass.)|September 27, 2022
Mitotic Checkpoints and the Role of WEE1 Inhibition in Head and Neck Squamous Cell CarcinomaShihan N Khan, Paul L Swiecicki, Deborah B Doroshow
Facial Plastic Surgery : FPS|May 16, 2020
Targeted Therapy and Traditional Chemotherapy in Melanoma and Cutaneous Squamous Cell CarcinomaVincent T Ma, Catherine T Haring, Govind Warrier, et al.
Translational Cancer Research|August 12, 2025
First-line therapy for recurrent metastatic head and neck squamous cell carcinoma: every rose has its thornDena Hasan, J Chad Brenner, Paul L Swiecicki, et al.
Expert Review of Precision Medicine and Drug Development|March 3, 2017
A review of drugs in development for the personalized treatment of head and neck squamous cell carcinomaAndrew C Birkeland, Paul L Swiecicki, J Chad Brenner, et al.
Cancer|March 27, 2026
Baseline tumor burden and outcomes in patients with rare cancers treated with immunotherapy (Southwest Oncology Group trial S1609)Paul L Swiecicki, Megan Othus, Sandip P Patel, et al.
Frontiers in Genetics|May 16, 2022
Trans-Renal Cell-Free Tumor DNA for Urine-Based Liquid Biopsy of CancerSarah M Dermody, Chandan Bhambhani, Paul L Swiecicki, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Current Clinical Pharmacology|May 19, 2016
Axitinib in the Treatment of Head and Neck MalignanciesPaul L Swiecicki, Matthew Spector, Francis P Worden
World Journal of Clinical Oncology|February 11, 2016
Advanced oropharyngeal squamous cell carcinoma: Pathogenesis, treatment, and novel therapeutic approachesPaul L Swiecicki, Kelly M Malloy, Francis P Worden
Mayo Clinic Proceedings|August 6, 2013
35-year-old man with Fever and abdominal painLivia T Hegerova, Paul L Swiecicki, Shaji K Kumar
Blood|June 13, 2013
Cold agglutinin diseasePaul L Swiecicki, Livia T Hegerova, Morie A Gertz
Cancer Journal (Sudbury, Mass.)|September 27, 2022
Mitotic Checkpoints and the Role of WEE1 Inhibition in Head and Neck Squamous Cell CarcinomaShihan N Khan, Paul L Swiecicki, Deborah B Doroshow
Facial Plastic Surgery : FPS|May 16, 2020
Targeted Therapy and Traditional Chemotherapy in Melanoma and Cutaneous Squamous Cell CarcinomaVincent T Ma, Catherine T Haring, Govind Warrier, et al.
Translational Cancer Research|August 12, 2025
First-line therapy for recurrent metastatic head and neck squamous cell carcinoma: every rose has its thornDena Hasan, J Chad Brenner, Paul L Swiecicki, et al.
Expert Review of Precision Medicine and Drug Development|March 3, 2017
A review of drugs in development for the personalized treatment of head and neck squamous cell carcinomaAndrew C Birkeland, Paul L Swiecicki, J Chad Brenner, et al.
Cancer|March 27, 2026
Baseline tumor burden and outcomes in patients with rare cancers treated with immunotherapy (Southwest Oncology Group trial S1609)Paul L Swiecicki, Megan Othus, Sandip P Patel, et al.
Frontiers in Genetics|May 16, 2022
Trans-Renal Cell-Free Tumor DNA for Urine-Based Liquid Biopsy of CancerSarah M Dermody, Chandan Bhambhani, Paul L Swiecicki, et al.
Pageof 8